Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Blandino

Showing results (1-10 of 304) with videos related to

Pageof 31
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|May 1, 2020
Cancer at the time of the COVID-19 hurricaneGiovanni Blandino
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2021
Drugging the Master Regulator TP53 in Cancer: Mission Possible?Giovanni Blandino
Cell Death and Differentiation|April 29, 2023
Activated KRAS, polyamines, iASPP and TME: a multiple liaison in pancreatic cancerGiovanni Blandino
Cell Cycle (Georgetown, Tex.)|November 9, 2010
p53: The pivot between cell cycle arrest and senescenceRaffaela Santoro, Giovanni Blandino
EMBO Reports|April 19, 2019
cTAZ: a safeguard factor of antiviral responseSabrina Strano, Giovanni Blandino
Microrna (Shariqah, United Arab Emirates)|July 30, 2014
MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatmentFrancesco Fazi, Giovanni Blandino
Journal of Experimental & Clinical Cancer Research : CR|May 8, 2021
José Baselga M.D., Ph.D. (1959-2021) leading cancer researcher and oncologistMoshe Elkabets, Giovanni Blandino
Digestive Diseases and Sciences|September 19, 2025
Learning from Yeast-How YEATS Domain Proteins Read Epigenetic Marks Driving Oncogenic Programs in Gastrointestinal TumorsValeria Canu, Giovanni Blandino
Cell Cycle (Georgetown, Tex.)|July 16, 2004
p73 and p63: why do we still need them?Giovanni Blandino, Matthias Dobbelstein
Frontiers in Oncology|July 28, 2016
Editorial: Human Tumor-Derived p53 Mutants: A Growing Family of OncoproteinsYgal Haupt, Giovanni Blandino
Pageof 31

Showing results (1-10 of 304) with videos related to

Sort By:
Pageof 31
Journal of Experimental & Clinical Cancer Research : CR|May 1, 2020
Cancer at the time of the COVID-19 hurricaneGiovanni Blandino
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2021
Drugging the Master Regulator TP53 in Cancer: Mission Possible?Giovanni Blandino
Cell Death and Differentiation|April 29, 2023
Activated KRAS, polyamines, iASPP and TME: a multiple liaison in pancreatic cancerGiovanni Blandino
Cell Cycle (Georgetown, Tex.)|November 9, 2010
p53: The pivot between cell cycle arrest and senescenceRaffaela Santoro, Giovanni Blandino
EMBO Reports|April 19, 2019
cTAZ: a safeguard factor of antiviral responseSabrina Strano, Giovanni Blandino
Microrna (Shariqah, United Arab Emirates)|July 30, 2014
MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatmentFrancesco Fazi, Giovanni Blandino
Journal of Experimental & Clinical Cancer Research : CR|May 8, 2021
José Baselga M.D., Ph.D. (1959-2021) leading cancer researcher and oncologistMoshe Elkabets, Giovanni Blandino
Digestive Diseases and Sciences|September 19, 2025
Learning from Yeast-How YEATS Domain Proteins Read Epigenetic Marks Driving Oncogenic Programs in Gastrointestinal TumorsValeria Canu, Giovanni Blandino
Cell Cycle (Georgetown, Tex.)|July 16, 2004
p73 and p63: why do we still need them?Giovanni Blandino, Matthias Dobbelstein
Frontiers in Oncology|July 28, 2016
Editorial: Human Tumor-Derived p53 Mutants: A Growing Family of OncoproteinsYgal Haupt, Giovanni Blandino
Pageof 31